← Open Payments lookup

RUBEN PINERO FUENTES: Open Payments

NPI 1710326046 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$70,536 in 108 payments from 10 companies in 2025. Trend: 2023 $1,346 · 2024 $1,387 · 2025 $70,536

Speaker / faculty: $56,522Consulting: $6,200Travel & lodging: $5,514Food & beverage: $2,300
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.53$39,854
Neurocrine BioSciences, Inc.25$30,009
E.R. Squibb & Sons, L.L.C.9$223
Alkermes, Inc.13$168
Janssen Pharmaceuticals, Inc1$121
Otsuka America Pharmaceutical, Inc.3$76
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$24
Otsuka Pharmaceutical Development & Commercialization, Inc.1$23
ABBVIE INC.1$20
Vanda Pharmaceuticals Inc.1$18

Products named: UZEDY, INGREZZA, AUSTEDO XR, COBENFY, ARISTADA, INVEGA SUSTENNA, REXULTI, CAPLYTA.

Industry payments across TX — which companies pay providers there.